nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—ABCC6—Teniposide—lymphatic system cancer	0.242	0.296	CbGbCtD
Indomethacin—ABCC11—Methotrexate—lymphatic system cancer	0.123	0.15	CbGbCtD
Indomethacin—ABCC3—Vincristine—lymphatic system cancer	0.056	0.0684	CbGbCtD
Indomethacin—ABCC1—Mitoxantrone—lymphatic system cancer	0.05	0.061	CbGbCtD
Indomethacin—ABCC1—Vincristine—lymphatic system cancer	0.0344	0.042	CbGbCtD
Indomethacin—ABCC3—Methotrexate—lymphatic system cancer	0.0339	0.0414	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—lymphatic system cancer	0.0278	0.034	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—lymphatic system cancer	0.0265	0.0324	CbGbCtD
Indomethacin—ABCC4—Methotrexate—lymphatic system cancer	0.0259	0.0316	CbGbCtD
Indomethacin—ABCC2—Vincristine—lymphatic system cancer	0.0254	0.0311	CbGbCtD
Indomethacin—CYP2C19—Teniposide—lymphatic system cancer	0.0214	0.0261	CbGbCtD
Indomethacin—ABCC1—Methotrexate—lymphatic system cancer	0.0208	0.0254	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—lymphatic system cancer	0.0186	0.0227	CbGbCtD
Indomethacin—CYP2C9—Teniposide—lymphatic system cancer	0.0178	0.0217	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—lymphatic system cancer	0.0175	0.0214	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—lymphatic system cancer	0.0162	0.0198	CbGbCtD
Indomethacin—ABCC2—Methotrexate—lymphatic system cancer	0.0154	0.0188	CbGbCtD
Indomethacin—ABCB1—Mitoxantrone—lymphatic system cancer	0.0121	0.0147	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—lymphatic system cancer	0.0113	0.0138	CbGbCtD
Indomethacin—ALB—Methotrexate—lymphatic system cancer	0.0096	0.0117	CbGbCtD
Indomethacin—ABCB1—Vincristine—lymphatic system cancer	0.0083	0.0101	CbGbCtD
Indomethacin—ABCB1—Methotrexate—lymphatic system cancer	0.00502	0.00613	CbGbCtD
Indomethacin—ABCC6—Podofilox—Teniposide—lymphatic system cancer	0.0021	0.358	CbGdCrCtD
Indomethacin—AKR1C3—Podofilox—Teniposide—lymphatic system cancer	0.00184	0.313	CbGdCrCtD
Indomethacin—PPARG—Etoposide—Teniposide—lymphatic system cancer	0.00118	0.202	CbGdCrCtD
Indomethacin—AKR1C3—Vinblastine—Vincristine—lymphatic system cancer	0.000751	0.128	CbGdCrCtD
Indomethacin—Stomatitis—Mitoxantrone—lymphatic system cancer	0.000348	0.00199	CcSEcCtD
Indomethacin—Jaundice—Mitoxantrone—lymphatic system cancer	0.000348	0.00199	CcSEcCtD
Indomethacin—Haemoglobin—Carmustine—lymphatic system cancer	0.000346	0.00198	CcSEcCtD
Indomethacin—Urticaria—Teniposide—lymphatic system cancer	0.000346	0.00197	CcSEcCtD
Indomethacin—Oliguria—Methotrexate—lymphatic system cancer	0.000345	0.00197	CcSEcCtD
Indomethacin—Haemorrhage—Carmustine—lymphatic system cancer	0.000345	0.00197	CcSEcCtD
Indomethacin—Abdominal pain—Teniposide—lymphatic system cancer	0.000344	0.00196	CcSEcCtD
Indomethacin—Body temperature increased—Teniposide—lymphatic system cancer	0.000344	0.00196	CcSEcCtD
Indomethacin—Erythema—Bleomycin—lymphatic system cancer	0.000344	0.00196	CcSEcCtD
Indomethacin—Paraesthesia—Fludarabine—lymphatic system cancer	0.000343	0.00196	CcSEcCtD
Indomethacin—Sweating—Mitoxantrone—lymphatic system cancer	0.000342	0.00195	CcSEcCtD
Indomethacin—Dyspnoea—Fludarabine—lymphatic system cancer	0.000341	0.00195	CcSEcCtD
Indomethacin—Haematuria—Mitoxantrone—lymphatic system cancer	0.00034	0.00194	CcSEcCtD
Indomethacin—Dyspepsia—Fludarabine—lymphatic system cancer	0.000337	0.00192	CcSEcCtD
Indomethacin—Dysarthria—Methotrexate—lymphatic system cancer	0.000336	0.00192	CcSEcCtD
Indomethacin—Ulcer—Methotrexate—lymphatic system cancer	0.000336	0.00192	CcSEcCtD
Indomethacin—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.000333	0.0019	CcSEcCtD
Indomethacin—Decreased appetite—Fludarabine—lymphatic system cancer	0.000333	0.0019	CcSEcCtD
Indomethacin—Fatigue—Fludarabine—lymphatic system cancer	0.00033	0.00188	CcSEcCtD
Indomethacin—Constipation—Fludarabine—lymphatic system cancer	0.000327	0.00187	CcSEcCtD
Indomethacin—Pain—Fludarabine—lymphatic system cancer	0.000327	0.00187	CcSEcCtD
Indomethacin—Bradycardia—Mitoxantrone—lymphatic system cancer	0.000326	0.00186	CcSEcCtD
Indomethacin—Vasculitis—Methotrexate—lymphatic system cancer	0.000326	0.00186	CcSEcCtD
Indomethacin—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.000322	0.00184	CcSEcCtD
Indomethacin—Hypersensitivity—Teniposide—lymphatic system cancer	0.000321	0.00183	CcSEcCtD
Indomethacin—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00032	0.00183	CcSEcCtD
Indomethacin—Hepatitis—Mitoxantrone—lymphatic system cancer	0.00032	0.00183	CcSEcCtD
Indomethacin—Flushing—Carmustine—lymphatic system cancer	0.00032	0.00183	CcSEcCtD
Indomethacin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.000319	0.00182	CcSEcCtD
Indomethacin—Anaemia—Bleomycin—lymphatic system cancer	0.000318	0.00181	CcSEcCtD
Indomethacin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.000315	0.0018	CcSEcCtD
Indomethacin—Asthenia—Teniposide—lymphatic system cancer	0.000312	0.00178	CcSEcCtD
Indomethacin—Malaise—Bleomycin—lymphatic system cancer	0.00031	0.00177	CcSEcCtD
Indomethacin—Pruritus—Teniposide—lymphatic system cancer	0.000308	0.00176	CcSEcCtD
Indomethacin—Arrhythmia—Carmustine—lymphatic system cancer	0.000308	0.00176	CcSEcCtD
Indomethacin—Leukopenia—Bleomycin—lymphatic system cancer	0.000308	0.00176	CcSEcCtD
Indomethacin—Alopecia—Carmustine—lymphatic system cancer	0.000304	0.00174	CcSEcCtD
Indomethacin—Skin exfoliation—Methotrexate—lymphatic system cancer	0.000303	0.00173	CcSEcCtD
Indomethacin—Body temperature increased—Fludarabine—lymphatic system cancer	0.000302	0.00173	CcSEcCtD
Indomethacin—Erythema—Carmustine—lymphatic system cancer	0.0003	0.00171	CcSEcCtD
Indomethacin—Aplastic anaemia—Methotrexate—lymphatic system cancer	0.000298	0.0017	CcSEcCtD
Indomethacin—Diarrhoea—Teniposide—lymphatic system cancer	0.000298	0.0017	CcSEcCtD
Indomethacin—Chest pain—Bleomycin—lymphatic system cancer	0.000293	0.00167	CcSEcCtD
Indomethacin—Alopecia—Vincristine—lymphatic system cancer	0.000291	0.00166	CcSEcCtD
Indomethacin—Coma—Methotrexate—lymphatic system cancer	0.00029	0.00166	CcSEcCtD
Indomethacin—Discomfort—Bleomycin—lymphatic system cancer	0.000289	0.00165	CcSEcCtD
Indomethacin—Ecchymosis—Methotrexate—lymphatic system cancer	0.000287	0.00164	CcSEcCtD
Indomethacin—Mouth ulceration—Methotrexate—lymphatic system cancer	0.000287	0.00164	CcSEcCtD
Indomethacin—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.000286	0.00163	CcSEcCtD
Indomethacin—Gynaecomastia—Methotrexate—lymphatic system cancer	0.000284	0.00162	CcSEcCtD
Indomethacin—Alopecia—Mitoxantrone—lymphatic system cancer	0.000283	0.00162	CcSEcCtD
Indomethacin—Pulmonary oedema—Methotrexate—lymphatic system cancer	0.000283	0.00162	CcSEcCtD
Indomethacin—Confusional state—Bleomycin—lymphatic system cancer	0.000283	0.00161	CcSEcCtD
Indomethacin—Vision blurred—Carmustine—lymphatic system cancer	0.000283	0.00161	CcSEcCtD
Indomethacin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.000282	0.00161	CcSEcCtD
Indomethacin—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00028	0.0016	CcSEcCtD
Indomethacin—Oedema—Bleomycin—lymphatic system cancer	0.00028	0.0016	CcSEcCtD
Indomethacin—Erythema—Mitoxantrone—lymphatic system cancer	0.000279	0.00159	CcSEcCtD
Indomethacin—Anaemia—Carmustine—lymphatic system cancer	0.000277	0.00158	CcSEcCtD
Indomethacin—Vomiting—Teniposide—lymphatic system cancer	0.000277	0.00158	CcSEcCtD
Indomethacin—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.000275	0.00157	CcSEcCtD
Indomethacin—Asthenia—Fludarabine—lymphatic system cancer	0.000274	0.00157	CcSEcCtD
Indomethacin—Rash—Teniposide—lymphatic system cancer	0.000274	0.00157	CcSEcCtD
Indomethacin—Dermatitis—Teniposide—lymphatic system cancer	0.000274	0.00157	CcSEcCtD
Indomethacin—Headache—Teniposide—lymphatic system cancer	0.000273	0.00156	CcSEcCtD
Indomethacin—Pruritus—Fludarabine—lymphatic system cancer	0.000271	0.00155	CcSEcCtD
Indomethacin—Leukopenia—Carmustine—lymphatic system cancer	0.000269	0.00153	CcSEcCtD
Indomethacin—Anorexia—Bleomycin—lymphatic system cancer	0.000267	0.00153	CcSEcCtD
Indomethacin—Thrombophlebitis—Methotrexate—lymphatic system cancer	0.000267	0.00152	CcSEcCtD
Indomethacin—Anaemia—Vincristine—lymphatic system cancer	0.000265	0.00151	CcSEcCtD
Indomethacin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.000263	0.0015	CcSEcCtD
Indomethacin—Hypotension—Bleomycin—lymphatic system cancer	0.000262	0.0015	CcSEcCtD
Indomethacin—Diarrhoea—Fludarabine—lymphatic system cancer	0.000262	0.00149	CcSEcCtD
Indomethacin—Convulsion—Carmustine—lymphatic system cancer	0.00026	0.00148	CcSEcCtD
Indomethacin—Hypertension—Carmustine—lymphatic system cancer	0.000259	0.00148	CcSEcCtD
Indomethacin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.000259	0.00148	CcSEcCtD
Indomethacin—Nausea—Teniposide—lymphatic system cancer	0.000259	0.00148	CcSEcCtD
Indomethacin—Anaemia—Mitoxantrone—lymphatic system cancer	0.000258	0.00147	CcSEcCtD
Indomethacin—Vertigo—Vincristine—lymphatic system cancer	0.000257	0.00147	CcSEcCtD
Indomethacin—Leukopenia—Vincristine—lymphatic system cancer	0.000256	0.00146	CcSEcCtD
Indomethacin—Chest pain—Carmustine—lymphatic system cancer	0.000255	0.00146	CcSEcCtD
Indomethacin—Anxiety—Carmustine—lymphatic system cancer	0.000254	0.00145	CcSEcCtD
Indomethacin—Paraesthesia—Bleomycin—lymphatic system cancer	0.000252	0.00144	CcSEcCtD
Indomethacin—Malaise—Mitoxantrone—lymphatic system cancer	0.000251	0.00144	CcSEcCtD
Indomethacin—Dyspnoea—Bleomycin—lymphatic system cancer	0.00025	0.00143	CcSEcCtD
Indomethacin—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00025	0.00143	CcSEcCtD
Indomethacin—Convulsion—Vincristine—lymphatic system cancer	0.000248	0.00142	CcSEcCtD
Indomethacin—Hypertension—Vincristine—lymphatic system cancer	0.000247	0.00141	CcSEcCtD
Indomethacin—Confusional state—Carmustine—lymphatic system cancer	0.000247	0.00141	CcSEcCtD
Indomethacin—Oedema—Carmustine—lymphatic system cancer	0.000245	0.0014	CcSEcCtD
Indomethacin—Dermatitis exfoliative—Methotrexate—lymphatic system cancer	0.000245	0.0014	CcSEcCtD
Indomethacin—Decreased appetite—Bleomycin—lymphatic system cancer	0.000244	0.00139	CcSEcCtD
Indomethacin—Vomiting—Fludarabine—lymphatic system cancer	0.000243	0.00139	CcSEcCtD
Indomethacin—Convulsion—Mitoxantrone—lymphatic system cancer	0.000242	0.00138	CcSEcCtD
Indomethacin—Rash—Fludarabine—lymphatic system cancer	0.000241	0.00138	CcSEcCtD
Indomethacin—Dermatitis—Fludarabine—lymphatic system cancer	0.000241	0.00138	CcSEcCtD
Indomethacin—Hypertension—Mitoxantrone—lymphatic system cancer	0.000241	0.00137	CcSEcCtD
Indomethacin—Pain—Bleomycin—lymphatic system cancer	0.00024	0.00137	CcSEcCtD
Indomethacin—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00024	0.00137	CcSEcCtD
Indomethacin—Headache—Fludarabine—lymphatic system cancer	0.00024	0.00137	CcSEcCtD
Indomethacin—Tachycardia—Carmustine—lymphatic system cancer	0.000239	0.00136	CcSEcCtD
Indomethacin—Chest pain—Mitoxantrone—lymphatic system cancer	0.000237	0.00136	CcSEcCtD
Indomethacin—Anxiety—Mitoxantrone—lymphatic system cancer	0.000237	0.00135	CcSEcCtD
Indomethacin—Discomfort—Mitoxantrone—lymphatic system cancer	0.000235	0.00134	CcSEcCtD
Indomethacin—Anaphylactic shock—Vincristine—lymphatic system cancer	0.000234	0.00133	CcSEcCtD
Indomethacin—Oedema—Vincristine—lymphatic system cancer	0.000234	0.00133	CcSEcCtD
Indomethacin—Anorexia—Carmustine—lymphatic system cancer	0.000233	0.00133	CcSEcCtD
Indomethacin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.000231	0.00132	CcSEcCtD
Indomethacin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.000231	0.00132	CcSEcCtD
Indomethacin—Confusional state—Mitoxantrone—lymphatic system cancer	0.000229	0.00131	CcSEcCtD
Indomethacin—Thrombocytopenia—Vincristine—lymphatic system cancer	0.000229	0.00131	CcSEcCtD
Indomethacin—Hypotension—Carmustine—lymphatic system cancer	0.000229	0.00131	CcSEcCtD
Indomethacin—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.000228	0.0013	CcSEcCtD
Indomethacin—Oedema—Mitoxantrone—lymphatic system cancer	0.000228	0.0013	CcSEcCtD
Indomethacin—Nausea—Fludarabine—lymphatic system cancer	0.000227	0.0013	CcSEcCtD
Indomethacin—Hyperhidrosis—Vincristine—lymphatic system cancer	0.000226	0.00129	CcSEcCtD
Indomethacin—Shock—Mitoxantrone—lymphatic system cancer	0.000224	0.00128	CcSEcCtD
Indomethacin—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.000223	0.00127	CcSEcCtD
Indomethacin—Urticaria—Bleomycin—lymphatic system cancer	0.000223	0.00127	CcSEcCtD
Indomethacin—Anorexia—Vincristine—lymphatic system cancer	0.000223	0.00127	CcSEcCtD
Indomethacin—Tachycardia—Mitoxantrone—lymphatic system cancer	0.000222	0.00127	CcSEcCtD
Indomethacin—Body temperature increased—Bleomycin—lymphatic system cancer	0.000222	0.00127	CcSEcCtD
Indomethacin—Insomnia—Carmustine—lymphatic system cancer	0.000221	0.00126	CcSEcCtD
Indomethacin—Hyperhidrosis—Mitoxantrone—lymphatic system cancer	0.00022	0.00126	CcSEcCtD
Indomethacin—Paraesthesia—Carmustine—lymphatic system cancer	0.00022	0.00126	CcSEcCtD
Indomethacin—Hypotension—Vincristine—lymphatic system cancer	0.000218	0.00125	CcSEcCtD
Indomethacin—Dyspnoea—Carmustine—lymphatic system cancer	0.000218	0.00125	CcSEcCtD
Indomethacin—Somnolence—Carmustine—lymphatic system cancer	0.000218	0.00124	CcSEcCtD
Indomethacin—Anorexia—Mitoxantrone—lymphatic system cancer	0.000217	0.00124	CcSEcCtD
Indomethacin—Decreased appetite—Carmustine—lymphatic system cancer	0.000213	0.00122	CcSEcCtD
Indomethacin—Hypotension—Mitoxantrone—lymphatic system cancer	0.000213	0.00121	CcSEcCtD
Indomethacin—Insomnia—Vincristine—lymphatic system cancer	0.000211	0.00121	CcSEcCtD
Indomethacin—Paraesthesia—Vincristine—lymphatic system cancer	0.00021	0.0012	CcSEcCtD
Indomethacin—Pain—Carmustine—lymphatic system cancer	0.000209	0.0012	CcSEcCtD
Indomethacin—Constipation—Carmustine—lymphatic system cancer	0.000209	0.0012	CcSEcCtD
Indomethacin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.000208	0.00119	CcSEcCtD
Indomethacin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.000207	0.00118	CcSEcCtD
Indomethacin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.000204	0.00117	CcSEcCtD
Indomethacin—Decreased appetite—Vincristine—lymphatic system cancer	0.000203	0.00116	CcSEcCtD
Indomethacin—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.000203	0.00116	CcSEcCtD
Indomethacin—Somnolence—Mitoxantrone—lymphatic system cancer	0.000202	0.00116	CcSEcCtD
Indomethacin—Feeling abnormal—Carmustine—lymphatic system cancer	0.000202	0.00115	CcSEcCtD
Indomethacin—Fatigue—Vincristine—lymphatic system cancer	0.000201	0.00115	CcSEcCtD
Indomethacin—Asthenia—Bleomycin—lymphatic system cancer	0.000201	0.00115	CcSEcCtD
Indomethacin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0002	0.00114	CcSEcCtD
Indomethacin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0002	0.00114	CcSEcCtD
Indomethacin—Constipation—Vincristine—lymphatic system cancer	0.0002	0.00114	CcSEcCtD
Indomethacin—Pain—Vincristine—lymphatic system cancer	0.0002	0.00114	CcSEcCtD
Indomethacin—Asthma—Methotrexate—lymphatic system cancer	0.000199	0.00114	CcSEcCtD
Indomethacin—Pruritus—Bleomycin—lymphatic system cancer	0.000198	0.00113	CcSEcCtD
Indomethacin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.000198	0.00113	CcSEcCtD
Indomethacin—Fatigue—Mitoxantrone—lymphatic system cancer	0.000196	0.00112	CcSEcCtD
Indomethacin—Pain—Mitoxantrone—lymphatic system cancer	0.000195	0.00111	CcSEcCtD
Indomethacin—Constipation—Mitoxantrone—lymphatic system cancer	0.000195	0.00111	CcSEcCtD
Indomethacin—Body temperature increased—Carmustine—lymphatic system cancer	0.000194	0.00111	CcSEcCtD
Indomethacin—Abdominal pain—Carmustine—lymphatic system cancer	0.000194	0.00111	CcSEcCtD
Indomethacin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.000191	0.00109	CcSEcCtD
Indomethacin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.000191	0.00109	CcSEcCtD
Indomethacin—Pancytopenia—Methotrexate—lymphatic system cancer	0.000189	0.00108	CcSEcCtD
Indomethacin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.000188	0.00107	CcSEcCtD
Indomethacin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.000186	0.00106	CcSEcCtD
Indomethacin—Abdominal pain—Vincristine—lymphatic system cancer	0.000185	0.00106	CcSEcCtD
Indomethacin—Body temperature increased—Vincristine—lymphatic system cancer	0.000185	0.00106	CcSEcCtD
Indomethacin—Urticaria—Mitoxantrone—lymphatic system cancer	0.000181	0.00103	CcSEcCtD
Indomethacin—Hypersensitivity—Carmustine—lymphatic system cancer	0.00018	0.00103	CcSEcCtD
Indomethacin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00018	0.00103	CcSEcCtD
Indomethacin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00018	0.00103	CcSEcCtD
Indomethacin—Vomiting—Bleomycin—lymphatic system cancer	0.000178	0.00102	CcSEcCtD
Indomethacin—Drowsiness—Methotrexate—lymphatic system cancer	0.000178	0.00102	CcSEcCtD
Indomethacin—Depression—Methotrexate—lymphatic system cancer	0.000177	0.00101	CcSEcCtD
Indomethacin—Rash—Bleomycin—lymphatic system cancer	0.000177	0.00101	CcSEcCtD
Indomethacin—Dermatitis—Bleomycin—lymphatic system cancer	0.000177	0.00101	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.000176	0.00101	CcSEcCtD
Indomethacin—Asthenia—Carmustine—lymphatic system cancer	0.000176	0.001	CcSEcCtD
Indomethacin—Renal failure—Methotrexate—lymphatic system cancer	0.000175	0.000998	CcSEcCtD
Indomethacin—Stomatitis—Methotrexate—lymphatic system cancer	0.000173	0.00099	CcSEcCtD
Indomethacin—Hypersensitivity—Vincristine—lymphatic system cancer	0.000172	0.000983	CcSEcCtD
Indomethacin—Sweating—Methotrexate—lymphatic system cancer	0.00017	0.000973	CcSEcCtD
Indomethacin—Haematuria—Methotrexate—lymphatic system cancer	0.00017	0.000968	CcSEcCtD
Indomethacin—Epistaxis—Methotrexate—lymphatic system cancer	0.000168	0.000958	CcSEcCtD
Indomethacin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.000168	0.000958	CcSEcCtD
Indomethacin—Asthenia—Vincristine—lymphatic system cancer	0.000168	0.000958	CcSEcCtD
Indomethacin—Diarrhoea—Carmustine—lymphatic system cancer	0.000168	0.000957	CcSEcCtD
Indomethacin—Nausea—Bleomycin—lymphatic system cancer	0.000167	0.000951	CcSEcCtD
Indomethacin—Agranulocytosis—Methotrexate—lymphatic system cancer	0.000166	0.000948	CcSEcCtD
Indomethacin—Asthenia—Mitoxantrone—lymphatic system cancer	0.000163	0.000933	CcSEcCtD
Indomethacin—Dizziness—Carmustine—lymphatic system cancer	0.000162	0.000925	CcSEcCtD
Indomethacin—Haemoglobin—Methotrexate—lymphatic system cancer	0.00016	0.000916	CcSEcCtD
Indomethacin—Diarrhoea—Vincristine—lymphatic system cancer	0.00016	0.000913	CcSEcCtD
Indomethacin—Haemorrhage—Methotrexate—lymphatic system cancer	0.00016	0.000911	CcSEcCtD
Indomethacin—Hepatitis—Methotrexate—lymphatic system cancer	0.00016	0.000911	CcSEcCtD
Indomethacin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.000156	0.000889	CcSEcCtD
Indomethacin—Vomiting—Carmustine—lymphatic system cancer	0.000156	0.000889	CcSEcCtD
Indomethacin—Dizziness—Vincristine—lymphatic system cancer	0.000155	0.000883	CcSEcCtD
Indomethacin—Rash—Carmustine—lymphatic system cancer	0.000154	0.000882	CcSEcCtD
Indomethacin—Dermatitis—Carmustine—lymphatic system cancer	0.000154	0.000881	CcSEcCtD
Indomethacin—Headache—Carmustine—lymphatic system cancer	0.000153	0.000876	CcSEcCtD
Indomethacin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.000151	0.000862	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—lymphatic system cancer	0.000149	0.00085	CcSEcCtD
Indomethacin—Vomiting—Vincristine—lymphatic system cancer	0.000149	0.000849	CcSEcCtD
Indomethacin—Rash—Vincristine—lymphatic system cancer	0.000147	0.000841	CcSEcCtD
Indomethacin—Dermatitis—Vincristine—lymphatic system cancer	0.000147	0.000841	CcSEcCtD
Indomethacin—Headache—Vincristine—lymphatic system cancer	0.000146	0.000836	CcSEcCtD
Indomethacin—Nausea—Carmustine—lymphatic system cancer	0.000145	0.00083	CcSEcCtD
Indomethacin—Vomiting—Mitoxantrone—lymphatic system cancer	0.000145	0.000826	CcSEcCtD
Indomethacin—Rash—Mitoxantrone—lymphatic system cancer	0.000144	0.00082	CcSEcCtD
Indomethacin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000143	0.000819	CcSEcCtD
Indomethacin—Headache—Mitoxantrone—lymphatic system cancer	0.000143	0.000814	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—lymphatic system cancer	0.000141	0.000805	CcSEcCtD
Indomethacin—Erythema—Methotrexate—lymphatic system cancer	0.000139	0.000793	CcSEcCtD
Indomethacin—Nausea—Vincristine—lymphatic system cancer	0.000139	0.000793	CcSEcCtD
Indomethacin—Nausea—Mitoxantrone—lymphatic system cancer	0.000135	0.000772	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—lymphatic system cancer	0.000131	0.000748	CcSEcCtD
Indomethacin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000129	0.000736	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—lymphatic system cancer	0.000128	0.000733	CcSEcCtD
Indomethacin—Malaise—Methotrexate—lymphatic system cancer	0.000125	0.000716	CcSEcCtD
Indomethacin—Vertigo—Methotrexate—lymphatic system cancer	0.000125	0.000713	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—lymphatic system cancer	0.000124	0.00071	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—lymphatic system cancer	0.00012	0.000687	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—lymphatic system cancer	0.000118	0.000676	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—lymphatic system cancer	0.000117	0.000667	CcSEcCtD
Indomethacin—Confusional state—Methotrexate—lymphatic system cancer	0.000114	0.000653	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.000113	0.000648	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000111	0.000634	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—lymphatic system cancer	0.00011	0.000626	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—lymphatic system cancer	0.000108	0.000617	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—lymphatic system cancer	0.000106	0.000605	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—lymphatic system cancer	0.000103	0.000586	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000102	0.000581	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—lymphatic system cancer	0.000101	0.000577	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—lymphatic system cancer	0.000101	0.000576	CcSEcCtD
Indomethacin—Dyspepsia—Methotrexate—lymphatic system cancer	9.98e-05	0.00057	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—lymphatic system cancer	9.86e-05	0.000563	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—lymphatic system cancer	9.78e-05	0.000558	CcSEcCtD
Indomethacin—Pain—Methotrexate—lymphatic system cancer	9.7e-05	0.000554	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—lymphatic system cancer	9.34e-05	0.000534	CcSEcCtD
Indomethacin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	9.27e-05	0.00053	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—lymphatic system cancer	9.01e-05	0.000514	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—lymphatic system cancer	8.96e-05	0.000512	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—lymphatic system cancer	8.96e-05	0.000512	CcSEcCtD
Indomethacin—Hypersensitivity—Methotrexate—lymphatic system cancer	8.35e-05	0.000477	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—lymphatic system cancer	8.14e-05	0.000465	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—lymphatic system cancer	8.02e-05	0.000458	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—lymphatic system cancer	7.76e-05	0.000443	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—lymphatic system cancer	7.5e-05	0.000428	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—lymphatic system cancer	7.21e-05	0.000412	CcSEcCtD
Indomethacin—Rash—Methotrexate—lymphatic system cancer	7.15e-05	0.000408	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—lymphatic system cancer	7.14e-05	0.000408	CcSEcCtD
Indomethacin—Headache—Methotrexate—lymphatic system cancer	7.1e-05	0.000406	CcSEcCtD
Indomethacin—Nausea—Methotrexate—lymphatic system cancer	6.74e-05	0.000385	CcSEcCtD
